Skip to main content
PMC home page
Nature Communications logoLink to Nature Communications
. 2023 Mar 22;14:1593. doi: 10.1038/s41467-023-37338-7

Author Correction: Immunogenicity and efficacy of fourth BNT162b2 and mRNA1273 COVID-19 vaccine doses; three months follow-up

Michal Canetti 1,2, Noam Barda 3,4,5, Mayan Gilboa 1,2, Victoria Indenbaum 2,6, Michal Mandelboim 2,6, Tal Gonen 1,2, Keren Asraf 2,7, Yael Weiss-Ottolenghi 1,2, Sharon Amit 2,8, Ram Doolman 2,7, Ella Mendelson 2,6, Dror Harats 9, Laurence S Freedman 10, Yitshak Kreiss 2,9, Yaniv Lustig 2,6,11, Gili Regev-Yochay 1,2,✉
PMCID: PMC10032242  PMID: 36949080

Correction to: Nature Communications 10.1038/s41467-022-35480-2, published online 13 December 2022

The published version of the article contained an error in Figure 2, where the incorrect panel d had been included. This has been corrected in the HTML and PDF versions.

Articles from Nature Communications are provided here courtesy of Nature Publishing Group

RESOURCES